Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B StudyR L Capizzi, R Davis, B Powell, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Journal of the National Cancer Institute|October 6, 1993
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcomaJ M Pluda, L E Shay, A Foli, et al.
Cancer|October 15, 1992
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group BA B Kornblith, J Anderson, D F Cella, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
The New England Journal of Medicine|April 20, 2000
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study GroupA Schatzkin, E Lanza, D Corle, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Investigational New Drugs|January 1, 1987
Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B StudyR L Capizzi, R Davis, B Powell, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Journal of the National Cancer Institute|October 6, 1993
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcomaJ M Pluda, L E Shay, A Foli, et al.
Cancer|October 15, 1992
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group BA B Kornblith, J Anderson, D F Cella, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
The New England Journal of Medicine|April 20, 2000
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study GroupA Schatzkin, E Lanza, D Corle, et al.
Pageof 25